Research from Atrium Research, Atrium Research Corporation

Atrium Research

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis.

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Research from Atrium Research

Atrium Research Corporation

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis. 

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Equity Bottom-Up

<ul>
<li>DNG reported its 2025 guidance which includes revenue of $345-375M (+27% on realized sales) and net income of $14-17M.</li>
<li>Dynacor has received EIA approval to begin construction of a 50,000tpd pilot plant in Senegal and plans to be finished construction by Q1/26.</li>
<li>DNG plans $1B in sales by 2030, representing a ~3x from 2024E sales.</li>
</ul>


DNG reported its 2025 guidance which includes revenue of $345-375M (+27% on realized sales) and net income of $14-17M.
Dynacor has received EIA approval to begin construction of a 50,000tpd pilot plant in Senegal and plans to be finished construction by Q1/26.
DNG plans $1B in sales by 2030, representing a ~3x from 2024E sales.


DNG: Strong 2025 Guidance & Fast-Tracked Growth Plans

Dynacor Group

DNG: Strong 2025 Guidance & Fast-Tracked Growth Plans